AGF Management Ltd. acquired a new stake in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 11,499 shares of the company’s stock, valued at approximately $796,000.
A number of other large investors have also made changes to their positions in the stock. Daiwa Securities Group Inc. lifted its holdings in Henry Schein by 5.4% in the 4th quarter. Daiwa Securities Group Inc. now owns 16,486 shares of the company’s stock valued at $1,141,000 after purchasing an additional 850 shares in the last quarter. Isthmus Partners LLC raised its position in shares of Henry Schein by 2.8% in the fourth quarter. Isthmus Partners LLC now owns 9,888 shares of the company’s stock valued at $684,000 after buying an additional 266 shares during the last quarter. Amundi lifted its stake in shares of Henry Schein by 12.0% during the fourth quarter. Amundi now owns 736,637 shares of the company’s stock valued at $52,345,000 after buying an additional 79,056 shares during the period. PNC Financial Services Group Inc. lifted its stake in shares of Henry Schein by 0.5% during the fourth quarter. PNC Financial Services Group Inc. now owns 86,601 shares of the company’s stock valued at $5,993,000 after buying an additional 458 shares during the period. Finally, Edgestream Partners L.P. grew its stake in Henry Schein by 119.5% in the 4th quarter. Edgestream Partners L.P. now owns 10,472 shares of the company’s stock worth $725,000 after acquiring an additional 5,702 shares during the period. Institutional investors and hedge funds own 96.62% of the company’s stock.
Analyst Ratings Changes
HSIC has been the topic of a number of recent analyst reports. UBS Group reduced their price target on Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 26th. Jefferies Financial Group raised their price target on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and upped their price objective for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Mizuho started coverage on shares of Henry Schein in a report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price objective on the stock. Finally, Barrington Research restated an “outperform” rating and issued a $90.00 target price on shares of Henry Schein in a report on Wednesday, February 26th. Six research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $81.10.
Henry Schein Stock Up 1.1 %
Shares of Henry Schein stock opened at $70.58 on Friday. Henry Schein, Inc. has a twelve month low of $63.67 and a twelve month high of $82.49. The stock has a market cap of $8.76 billion, a price-to-earnings ratio of 29.05, a price-to-earnings-growth ratio of 2.13 and a beta of 0.90. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The company has a fifty day moving average price of $74.81 and a 200 day moving average price of $72.60.
Henry Schein (NASDAQ:HSIC – Get Free Report) last issued its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.04). The company had revenue of $3.19 billion during the quarter, compared to analysts’ expectations of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. Henry Schein’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the previous year, the company earned $0.66 EPS. Equities research analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.
Henry Schein Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
See Also
- Five stocks we like better than Henry Schein
- High Flyers: 3 Natural Gas Stocks for March 2022
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- How to Calculate Retirement Income: MarketBeat’s Calculator
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- Industrial Products Stocks Investing
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.